Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperglycemia × exemestane × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 Breast 1

Conditions

Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Tuberous Sclerosis 1 Neuroendocrine Tumors 1 Hyperglycemia 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

ziprasidone 1 relacorilant 1 pembrolizumab 1 exemestane 1 Vildagliptin 1 Tamoxifen 1 Olanzapine 1 Metformin 1 Letrozole 1 Fulvestrant 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300790 2025-07-29

METALLICA

MedSIR

Phase 2 Completed

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡